Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enora Dolivet

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Gynecology Obstetrics and Human Reproduction|May 25, 2018
A case-control study about foetal trauma during caesarean deliveryEnora Dolivet, Cécile Delesalle, Rémi Morello, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 27, 2020
AMeTHYST (AMbulatory HYsterectomy surgery). Feasibility of minimally invasive outpatient hysterectomy, a preliminary studyEnora Dolivet, Arthur Foulon, Thérèse Simonet, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 20, 2021
ACOSOG Z-0011 criteria impact on axillary surgery for early breast cancer in clinical practice: Evaluation in a retrospective cohort of 1900 patientsEnora Dolivet, Cécile Loaec, Alison Johnson, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 1, 2025
Time to reconsider the use of synthetic mesh in immediate prepectoral implant-based breast reconstruction: Impact of their use on short-term outcomesEléa Leroy, Laura Poirier, Hélène Planque, et al.
International Journal of Molecular Sciences|November 14, 2023
Synergy of the microRNA Ratio as a Promising Diagnosis Biomarker for Mucinous Borderline and Malignant Ovarian TumorsEnora Dolivet, Léopold Gaichies, Corinne Jeanne, et al.
Molecular Oncology|June 8, 2025
The anticancer effect of the HDAC inhibitor belinostat is enhanced by inhibitors of Bcl-x<sub>L</sub> or Mcl-1 in ovarian cancerCécilia Thomine, Sterenn Guillemot, Louis-Bastien Weiswald, et al.
Cell Death & Disease|March 28, 2026
UPR/ATF4/Noxa pathway overactivation through SERCA2 inhibition or ONC201 treatment combined with ABT-737 triggers apoptosis in chemoresistant ovarian cancer cells and patient-derived tumor organoidsSahra Messaoudi, Romane Florent, Louis-Bastien Weiswald, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 25, 2025
Automated Scoring to Assess RAD51-Mediated Homologous Recombination in Ovarian Patient-Derived Tumor OrganoidsLucie Thorel, Nicolas Elie, Pierre-Marie Morice, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 6, 2023
Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinomaLucie Thorel, Pierre-Marie Morice, Hippolyte Paysant, et al.
BMC Cancer|September 19, 2023
The TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancerJordane Divoux, Romane Florent, Margaux Jacobs, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Gynecology Obstetrics and Human Reproduction|May 25, 2018
A case-control study about foetal trauma during caesarean deliveryEnora Dolivet, Cécile Delesalle, Rémi Morello, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 27, 2020
AMeTHYST (AMbulatory HYsterectomy surgery). Feasibility of minimally invasive outpatient hysterectomy, a preliminary studyEnora Dolivet, Arthur Foulon, Thérèse Simonet, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 20, 2021
ACOSOG Z-0011 criteria impact on axillary surgery for early breast cancer in clinical practice: Evaluation in a retrospective cohort of 1900 patientsEnora Dolivet, Cécile Loaec, Alison Johnson, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 1, 2025
Time to reconsider the use of synthetic mesh in immediate prepectoral implant-based breast reconstruction: Impact of their use on short-term outcomesEléa Leroy, Laura Poirier, Hélène Planque, et al.
International Journal of Molecular Sciences|November 14, 2023
Synergy of the microRNA Ratio as a Promising Diagnosis Biomarker for Mucinous Borderline and Malignant Ovarian TumorsEnora Dolivet, Léopold Gaichies, Corinne Jeanne, et al.
Molecular Oncology|June 8, 2025
The anticancer effect of the HDAC inhibitor belinostat is enhanced by inhibitors of Bcl-x<sub>L</sub> or Mcl-1 in ovarian cancerCécilia Thomine, Sterenn Guillemot, Louis-Bastien Weiswald, et al.
Cell Death & Disease|March 28, 2026
UPR/ATF4/Noxa pathway overactivation through SERCA2 inhibition or ONC201 treatment combined with ABT-737 triggers apoptosis in chemoresistant ovarian cancer cells and patient-derived tumor organoidsSahra Messaoudi, Romane Florent, Louis-Bastien Weiswald, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 25, 2025
Automated Scoring to Assess RAD51-Mediated Homologous Recombination in Ovarian Patient-Derived Tumor OrganoidsLucie Thorel, Nicolas Elie, Pierre-Marie Morice, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 6, 2023
Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinomaLucie Thorel, Pierre-Marie Morice, Hippolyte Paysant, et al.
BMC Cancer|September 19, 2023
The TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancerJordane Divoux, Romane Florent, Margaux Jacobs, et al.
Pageof 2